In the interest of service and in recognition of the continuing challenges and efforts to address the COVID-19 pandemic, the Food and Drug Administration hereby extends the effectivity of Memorandum Circular No. 2020-001 entitled “Interim Guidelines for the Issuance of Provisional License to Operate (LTO) and Certificate of Product Notification (CPN) for Manufacturers of Rubbing Alcohol Products under the Center for Cosmetics Regulation and Research” issued on 19 March 2020 and its amendment, FDA Memorandum Circular No. 2020-001-A issued on 16 April 2020 until 31 December 2020.
For information and guidance.
Attachment:-> FDA Memorandum Circular No. 2020-001-B
SEE ALSO -> FDA Memorandum Circular No. 2020-001
SEE ALSO -> FDA Memorandum Circular No. 2020-001-A